CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia
Clinical trial NCT04785833 · UNKNOWN
Trial details
- NCT number
- NCT04785833
- Sponsor
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-04
- Primary completion
- 2022-04-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.